Mark Aplin

844 total citations
31 papers, 650 citations indexed

About

Mark Aplin is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark Aplin has authored 31 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark Aplin's work include Receptor Mechanisms and Signaling (10 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Cardiovascular Function and Risk Factors (6 papers). Mark Aplin is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Cardiovascular Function and Risk Factors (6 papers). Mark Aplin collaborates with scholars based in Denmark, United Kingdom and Australia. Mark Aplin's co-authors include Jakob Lerche Hansen, Søren P. Sheikh, Mikael Schneider, Gitte Lund Christensen, Juliane Theilade, Stig Haunsø, Steen Gammeltoft, Arne Heydorn, Tue E. H. Christoffersen and Anne Louise Kjølbye and has published in prestigious journals such as PLoS ONE, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Mark Aplin

28 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Aplin Denmark	14	365	334	95	62	62	31	650
Rajaganapathi Jagannathan United States	13	521 1.4×	134 0.4×	65 0.7×	64 1.0×	41 0.7×	20	691
Heigoro Shirai United States	12	526 1.4×	464 1.4×	114 1.2×	73 1.2×	27 0.4×	14	896
Domenico M. Taglieri United States	12	377 1.0×	394 1.2×	57 0.6×	28 0.5×	27 0.4×	14	617
S.F. Brady United Kingdom	7	285 0.8×	356 1.1×	72 0.8×	28 0.5×	50 0.8×	11	622
Nakon Aroonsakool United States	11	394 1.1×	145 0.4×	52 0.5×	78 1.3×	24 0.4×	14	652
Yasutaka Moriguchi Japan	8	442 1.2×	459 1.4×	38 0.4×	62 1.0×	27 0.4×	8	745
Bun-Seng Tea Canada	10	424 1.2×	437 1.3×	45 0.5×	76 1.2×	15 0.2×	10	791
Jutta Meyer-Kirchrath Germany	15	211 0.6×	146 0.4×	42 0.4×	52 0.8×	22 0.4×	24	652
Even Holt Norway	11	325 0.9×	468 1.4×	64 0.7×	105 1.7×	24 0.4×	13	647
Edith Giasson Canada	9	396 1.1×	169 0.5×	51 0.5×	33 0.5×	13 0.2×	9	560

Countries citing papers authored by Mark Aplin

Since Specialization

Citations

This map shows the geographic impact of Mark Aplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Aplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Aplin more than expected).

Fields of papers citing papers by Mark Aplin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Aplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Aplin. The network helps show where Mark Aplin may publish in the future.

Co-authorship network of co-authors of Mark Aplin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Aplin. A scholar is included among the top collaborators of Mark Aplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Aplin. Mark Aplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aplin, Mark, et al.. (2026). Left atrial cardiomyopathy: association with atrial fibrillation and stroke recurrence. The International Journal of Cardiovascular Imaging.

Langsted, Anne, Børge G. Nordestgaard, Caroline Kistorp, et al.. (2025). Prevalence of obesity among adult patients with congenital heart disease: A population-based study. International Journal of Cardiology. 425. 133032–133032. 2 indexed citations

Larsen, Bjørn Strøier, Mark Aplin, Louisa Christensen, et al.. (2024). Left atrial cardiomyopathy predicts stroke recurrence and atrial fibrillation. European Heart Journal. 45(Supplement_1).

Larsen, Bjørn Strøier, Litten Bertelsen, Hanne Christensen, et al.. (2023). Left atrial late gadolinium enhancement in patients with ischaemic stroke. European Heart Journal - Cardiovascular Imaging. 24(5). 625–634. 5 indexed citations

Larsen, Bjørn Strøier, Mark Aplin, Nis Høst, et al.. (2022). Atrial cardiomyopathy in patients with ischaemic stroke: a cross-sectional and prospective cohort study—the COAST study. BMJ Open. 12(5). e061018–e061018. 4 indexed citations

Keramida, Georgia, et al.. (2019). Relationship between regional hepatic glucose metabolism and regional distribution of hepatic fat. Nuclear Medicine Communications. 40(3). 212–218. 2 indexed citations

Keramida, Georgia, et al.. (2017). Importance of accurate ilio-inguinal quantification in lower extremity lymphoscintigraphy. Nuclear Medicine Communications. 38(3). 209–214. 8 indexed citations

Dizdarevic, Sabina, Adam de Belder, Nicola Ryan, et al.. (2015). Early gated SPECT adenosine myocardial perfusion imaging may influence the therapeutic management of patients with coronary artery disease. Nuclear Medicine Communications. 36(4). 386–391. 1 indexed citations

Dizdarevic, Sabina, Mark Aplin, Melanie J. Newport, et al.. (2014). Old tracer for a new purpose. Nuclear Medicine Communications. 35(10). 1058–1066. 3 indexed citations

10.

Iismaa, Siiri E., Mark Aplin, Sara Holman, et al.. (2013). Glucose Homeostasis in Mice Is Transglutaminase 2 Independent. PLoS ONE. 8(5). e63346–e63346. 22 indexed citations

11.

Christensen, Gitte Lund, Bo Hjorth Bentzen, Bo Liang, et al.. (2012). Functionally Selective AT₁Receptor Activation Reduces Ischemia Reperfusion Injury. Cellular Physiology and Biochemistry. 30(3). 642–652. 15 indexed citations

12.

Christensen, Gitte Lund, Mark Aplin, & Jakob Lerche Hansen. (2010). Therapeutic Potential of Functional Selectivity in the Treatment of Heart Failure. Trends in Cardiovascular Medicine. 20(7). 221–227. 4 indexed citations

13.

Aplin, Mark, Gitte Lund Christensen, & Jakob Lerche Hansen. (2008). Pharmacologic Perspectives of Functional Selectivity by the Angiotensin II Type 1 Receptor. Trends in Cardiovascular Medicine. 18(8). 305–312. 20 indexed citations

14.

Schneider, Mikael, Sawa Kostin, Charlotte Strøm, et al.. (2007). S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. Cardiovascular Research. 75(1). 40–50. 127 indexed citations

15.

Aplin, Mark, Gitte Lund Christensen, Mikael Schneider, et al.. (2007). The Angiotensin Type 1 Receptor Activates Extracellular Signal‐Regulated Kinases 1 and 2 by G Protein‐Dependent and ‐Independent Pathways in Cardiac Myocytes and Langendorff‐Perfused Hearts. Basic & Clinical Pharmacology & Toxicology. 100(5). 289–295. 55 indexed citations

16.

Aplin, Mark, Gitte Lund Christensen, Mikael Schneider, et al.. (2007). Differential Extracellular Signal‐Regulated Kinases 1 and 2 Activation by the Angiotensin Type 1 Receptor Supports Distinct Phenotypes of Cardiac Myocytes. Basic & Clinical Pharmacology & Toxicology. 100(5). 296–301. 63 indexed citations

17.

Hansen, Jakob Lerche, Juliane Theilade, Mark Aplin, & Søren P. Sheikh. (2006). Role of G-Protein-Coupled Receptor Kinase 2 in the Heart—Do Regulatory Mechanisms Open Novel Therapeutic Perspectives?. Trends in Cardiovascular Medicine. 16(5). 169–177. 20 indexed citations

18.

Aplin, Mark, Thorkil Ploug, Tue E. H. Christoffersen, et al.. (2005). Expression profiling reveals differences in metabolic gene expression between exercise‐induced cardiac effects and maladaptive cardiac hypertrophy. FEBS Journal. 272(11). 2684–2695. 112 indexed citations

19.

Christoffersen, Tue E. H., Mark Aplin, Søren P. Sheikh, et al.. (2005). Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy. American Journal of Physiology-Heart and Circulatory Physiology. 290(4). H1635–H1641. 21 indexed citations

20.

Aplin, Mark, Thomas Engstrøm, Niels Vejlstrup, et al.. (2003). Prognostic importance of complete atrioventricular block complicating acute myocardial infarction. The American Journal of Cardiology. 92(7). 853–856. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact